| Literature DB >> 30595684 |
Tae Jung Kim1, Ji Sung Lee2, Ji-Woo Kim3, Mi Sun Oh4, Heejung Mo1, Chan-Hyuk Lee1, Han-Young Jeong1, Keun-Hwa Jung1, Jae-Sung Lim4, Sang-Bae Ko1, Kyung-Ho Yu4, Byung-Chul Lee4, Byung-Woo Yoon1.
Abstract
BACKGROUND: Linkage of public healthcare data is useful in stroke research because patients may visit different sectors of the health system before, during, and after stroke. Therefore, we aimed to establish high-quality big data on stroke in Korea by linking acute stroke registry and national health claim databases.Entities:
Keywords: Big Data; Data Linkage; National Health Claim Data; Stroke Registry
Mesh:
Year: 2018 PMID: 30595684 PMCID: PMC6306322 DOI: 10.3346/jkms.2018.33.e343
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Fig. 1Flow diagram of included cases for matching.
CRCS DB = Clinical Research Center for Stroke database.
Baseline characteristics of matched cases according to linkage status
| Variables | True matches (n = 61,017) | False matches (n = 3,617) | ASD | ||
|---|---|---|---|---|---|
| Age, mean ± SD, yr | 66.4 ± 12.7 | 66.7 ± 11.8 | 0.155 | 0.023 | |
| Gender, men, No. (%) | 35,631 (58.4) | 1,990 (55.0) | < 0.001 | 0.068 | |
| HTN, No. (%) | 42,934 (70.4) | 2,497 (69.0) | 0.089 | 0.029 | |
| DM, No. (%) | 20,411 (33.5) | 1,221 (33.8) | 0.705 | 0.006 | |
| HL, No. (%) | 17,805 (29.2) | 846 (23.4) | < 0.001 | 0.132 | |
| Previous stroke Hx., No. (%) | 10,662 (17.5) | 759 (21.0) | < 0.001 | 0.089 | |
| Coronary heart disease, No. (%) | 4,544 (7.4) | 177 (4.9) | < 0.001 | 0.106 | |
| A.fib, No. (%) | 10,592 (17.4) | 526 (14.5) | < 0.001 | 0.077 | |
| Smoking, No. (%) | 23,720 (38.9) | 1,196 (33.1) | < 0.001 | 0.121 | |
| Initial NIHSS, median (IQR) | 3 (1–7) | 3 (1–7) | 0.120 | 0.021 | |
| Types of stroke, No. (%) | < 0.001 | ||||
| Ischemic stroke | 52,213 (91.1) | 3,020 (91.1) | 0.001 | ||
| Hemorrhagic stroke | 1,113 (1.9) | 100 (3.0) | 0.069 | ||
| TIA | 3,988 (7.0) | 194 (5.9) | 0.045 | ||
| Stroke mechanisms, No. (%) | 0.149 | ||||
| LAA | 18,236 (34.9) | 1,018 (33.7) | 0.026 | ||
| SVO | 12,617 (24.2) | 784 (26.0) | 0.041 | ||
| CE | 9,736 (18.6) | 535 (17.7) | 0.024 | ||
| Other determined | 1,337 (2.6) | 83 (2.7) | 0.012 | ||
| Undetermined | 10,287 (19.7) | 600 (19.9) | 0.004 | ||
| Recanalization treatment, No. (%) | 8,457 (13.9) | 347 (9.6) | |||
| IV thrombolysis | 5,706 (67.5) | 221 (63.7) | < 0.001 | 0.122 | |
| Endovascular treatment | 1,353 (16.0) | 76 (21.9) | 0.644 | 0.008 | |
| Combined IV thrombolysis and endovascular treatment | 1,398 (16.5) | 50 (14.4) | < 0.001 | 0.068 | |
ASD = absolute standardized difference, SD = standard deviation, HTN = hypertension, DM = diabetes mellitus, HL = hyperlipidemia, Hx. = history, A.fib = atrial fibrillation, NIHSS = national institute of health stroke scale, IQR = interquartile range, TIA = transient ischemic attack, LAA = large artery atherosclerosis, SVO = small vessel occlusion, CE = cardioembolism, IV = intravenous.